Mannkind (MNKD) Leases (2021 - 2026)
Mannkind (MNKD) reported Leases of $11.3 million for Q1 2026, down 10.14% year-over-year from $12.6 million in Q1 2025, and down 4.49% on a QoQ basis from $11.8 million in Q4 2025.
Mannkind (MNKD) has 6 years of Leases data on file, last reported at $11.3 million in Q1 2026.
- Quarterly Leases fell 10.14% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (down 10.14% YoY) and the FY2025 annual result came in at $11.8 million, down 9.82% from the prior year.
- Leases slipped to $11.3 million in Q1 2026 per MNKD's latest filing, from $11.8 million in the prior quarter.
- Across five years, Leases topped out at $13.6 million in Q3 2024 and bottomed at $1.4 million in Q2 2022.
- The 5-year median for Leases is $6.9 million (2022), against an average of $8.1 million.
- Peak annual rise in Leases reached 280.64% in 2023, while the deepest fall reached 30.22% in 2023.
- Tracing MNKD's Leases over 5 years: stood at $6.7 million in 2022, then slumped by 30.22% to $4.7 million in 2023, then jumped by 179.81% to $13.1 million in 2024, then fell by 9.82% to $11.8 million in 2025, then declined by 4.49% to $11.3 million in 2026.
- Per Business Quant, the three latest MNKD Leases figures stand at $11.3 million (Q1 2026), $11.8 million (Q4 2025), and $11.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 11.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.29 Mn |
| Dec 31, 2025 | 11.82 Mn |
| Sep 30, 2025 | 11.29 Mn |
| Jun 30, 2025 | 11.79 Mn |
| Mar 31, 2025 | 12.57 Mn |
| Dec 31, 2024 | 13.11 Mn |
| Sep 30, 2024 | 13.64 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 4.39 Mn |
| Dec 31, 2023 | 4.69 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 5.33 Mn |
| Mar 31, 2023 | 5.65 Mn |
| Dec 31, 2022 | 6.71 Mn |
| Sep 30, 2022 | 7.05 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Dec 31, 2021 | 2.28 Mn |